REal-Life Cohort With DOlutegravir + LAmivudina
NCT04638686
·
clinicaltrials.gov ↗
COMPLETED
Status
185
Enrollment
OTHER
Sponsor class
Conditions
HIV-1-infection
Interventions
DRUG:
Dolutegravir 50 MG
DRUG:
Lamivudine 300 MG
Sponsor
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz